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Abstract
Introduction: Macrophages comprise an essential component of the mammary microenvironment necessary for
normal gland development. However, there is no viable in vivo model to study their role in normal human breast
function. We hypothesized that adding primary human macrophages to the murine mammary gland would
enhance and provide a novel approach to examine immune-stromal cell interactions during the humanization
process.
Methods: Primary human macrophages, in the presence or absence of ectopic estrogen stimulation, were used to
humanize mouse mammary glands. Mechanisms of enhanced humanization were identified by cytokine/
chemokine ELISAs, zymography, western analysis, invasion and proliferation assays; results were confirmed with
immunohistological analysis.
Results: The combined treatment of macrophages and estrogen stimulation significantly enhanced the percentage
of the total gland humanized and the engraftment/outgrowth success rate. Timecourse analysis revealed the
disappearance of the human macrophages by two weeks post-injection, suggesting that the improved overall
growth and invasiveness of the fibroblasts provided a larger stromal bed for epithelial cell proliferation and
structure formation. Confirming their promotion of fibroblasts humanization, estrogen-stimulated macrophages
significantly enhanced fibroblast proliferation and invasion in vitro, as well as significantly increased proliferating cell
nuclear antigen (PCNA) positive cells in humanized glands. Cytokine/chemokine ELISAs, zymography and western
analyses identified TNFa and MMP9 as potential mechanisms by which estrogen-stimulated macrophages
enhanced humanization. Specific inhibitors to TNFa and MMP9 validated the effects of these molecules on
fibroblast behavior in vitro, as well as by immunohistochemical analysis of humanized glands for human-specific
MMP9 expression. Lastly, glands humanized with macrophages had enhanced engraftment and tumor growth
compared to glands humanized with fibroblasts alone.
Conclusions: Herein, we demonstrate intricate immune and stromal cell paracrine interactions in a humanized in
vivo model system. We confirmed our in vivo results with in vitro analyses, highlighting the value of this model to
interchangeably substantiate in vitro and in vivo results. It is critical to understand the signaling networks that drive
paracrine cell interactions, for tumor cells exploit these signaling mechanisms to support their growth and invasive
properties. This report presents a dynamic in vivo model to study primary human immune/fibroblast/epithelial
interactions and to advance our knowledge of the stromal-derived signals that promote tumorigenesis.
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Introduction
Mammary gland development and function depends on
intricate interactions of the functional epithelial cells
with local stromal cells, including fibroblasts, adipose,
endothelium, immune and nerve cells [1-4]. The mam-
mary gland is a particularly unique organ as the majority
of its development occurs postnatally. Systemic and
locally produced steroids and growth factors orchestrate
the outgrowth and differentiation of the epithelium
throughout the gland during puberty, followed by addi-
tional rounds of proliferation and differentiation during
pregnancy, lactation, and involution [1,3]. Furthermore,
analyses of breast tissue from human autopsy and surgi-
cal specimens suggest that additional morphologic
changes in the epithelium repeatedly occur during each
menstrual cycle [5]. These morphological changes are a
result of hormone- and growth factor-stimulated altera-
tions in proliferation, apoptosis, protein expression, and
cell kinetics. It is critical to understand the signaling
networks that drive these cyclic changes, for many of
the signaling mechanisms that control them are often
exploited by tumor cells to support their growth and
invasive properties.
Much of our knowledge about these processes in the
human breast has been extrapolated from mouse and
rat models. Attempts to recapitulate human breast mor-
phogenesis in the mouse mammary gland using direct
injections or collagen embedded cells failed to support
proliferation of breast epithelial cells in mouse models.
However, injection of human breast fibroblasts into the
cleared mammary fat pad prior to injection of human
breast epithelial cells (xenograft humanized mammary
gland model) [6] stimulates human epithelial cell prolif-
eration and promotes the organization of differentiated
acini structures, and leads to successful engraftment of
mouse mammary fat pads with human breast epithelial
cells. This innovative model allows the investigator to
observe fibroblast-epithelial interactions, with either
normal or cancer-derived cells, in an orthotopic in vivo
model.
In addition to fibroblasts, the homeostasis of breast
epithelial cells depends upon interactions with many dif-
ferent types of stromal cells. In particular, macrophages
comprise a vital, functional component of the mammary
microenvironment and are essential for normal mam-
mary gland development [7-10]. During development,
macrophages are recruited and localized in abundance
to the neck of the developing terminal end buds. Their
removal during postnatal development by either genetic
manipulation or gamma irradiation results in reduced
formation of terminal end buds and restricted out-
growth and branching of the epithelial ductal tree [9,11].
Although a plethora of data suggests a central role for
macrophages during mammary development, the precise
mechanisms remain unknown. It is hypothesized that
they promote epithelial growth throughout the gland by
supplying growth factors, proteases, cytokines and
angiogenic factors [12].
Macrophages play a role not only in normal mammary
development but also in breast cancer development,
progression, and metastasis. Consistent with cellular
alterations that occur during tumorigenesis, tumor-asso-
ciated macrophages (TAMs) display distinct phenotypes
and behavior compared to those in non-malignant tissue
[13]. TAMs secrete proteases that facilitate degradation
of basement membrane and extracellular matrix for
facilitation of tumor invasion and metastasis. Addition-
ally, TAMs supply epidermal growth factor (EGF) and
Wnt ligands that promote cell growth and vascular
remodeling, respectively [14-16]. Clinical data support
these observations; for example, a high density of TAMs
is correlated with poor prognosis and decreased survival
in breast cancer patients [16-18].
Given the fundamental role macrophages perform in
mammary development and function, as well as during
tumorigenesis, we hypothesized that the introduction of
human macrophages would enhance humanization of
the murine mammary gland and permit an intimate first
look at human immune and stromal-derived paracrine
cell interactions in a dynamic in vivo model. Herein, we
demonstrate that primary human peripheral blood
macrophages enhance humanization by enhancing fibro-
blast proliferation and engraftment of the mammary fat
pad, thereby providing a larger stromal bed for breast
epithelial growth and acini formation. We have identi-
fied two specific paracrine mechanisms involved in
enhancement of humanization: increased fibroblast pro-
liferation stimulated by macrophage-derived TNFa as
well as a macrophage-stimulated increase in matrix
metalloproteinase (MMP)-9 expression and proteinase
activity. Collectively, our data demonstrate intricate
mechanisms of primary human immune and stromal-
derived paracrine interactions in a humanized xenograft
model of the mammary gland.
Materials and methods
Collection and processing of patient samples and cell
culture
Collection of patient samples was performed in accor-
dance with the guidelines of the National Cancer Insti-
tute’s Institutional Review Board, under four separate
approved protocols OH99-C-NO57, 02-C-0077E, 04-C-
0199, OHSR4789, and 99-CC-0168. Written informed
consent was obtained from all human subjects as stipu-
lated by the protocols. Breast tissue was collected from
premenopausal fasting patients undergoing reduction
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mammoplasty. The tissue obtained for analyses was con-
sidered pathological medical waste; thus, any clinical
details of the women, apart from age and race, were
unattainable. A pathologist confirmed that each sample
was free of malignant or hyperplasic growth. Immedi-
ately after surgery a portion of tissue was used for
epithelial cell and organoid isolation as described [19];
an additional separate piece of tissue was used for isola-
tion of primary human breast fibroblasts, and the
remainder was snap frozen and stored at -80°C. Fibro-
blasts were isolated by placing < 5 mm pieces of tissue
on a scratched cell culture dish, and with time, the
fibroblasts crawled out of the tissue to form a mono-
layer on the dish. The fragments of tissue were removed
and the remaining fibroblasts were passaged and plated
as monolayer cultures, to expand and ensure fibroblast
purity. When necessary, epithelial cells were separated
from the stromal cells by differential trypsinization and
selective pressure with fibroblast growth medium,
DMEM containing 10% FCS (Invitrogen, Gaithersburg,
MD, USA). Fibroblasts were grown for a maximum of
three passages prior to analysis. Human telomerase
reverse transcriptase (hTERT)-immortalized breast
fibroblasts were a kind gift from Charlotte Kuperwasser
(Tufts University, Boston, MA, USA).
Peripheral blood monocytes and macrophages were
collected from premenopausal women undergoing
apheresis. Monocytes and macrophages were separated
from other cells using Ficoll-Hypaque (Sigma, St. Louis,
MO, USA) gradient separation and selection by adher-
ence to tissue culture plastic. Cells were grown in RPMI
containing 5% human serum (Invitrogen) for 24 hr then
changed to RPMI containing 5% FBS until differentia-
tion. Differentiation was performed via treatment with
20 ng/ml of IFNg and lipopolysaccharide (LPS, Sigma)
in 2% charcoal-stripped serum (Hyclone, Logan, UT,
USA) for 48 hr.
T47D breast cancer cells were obtained from Ameri-
can Type Tissue Culture Collection (Manassas, VA,
USA) and maintained in RPMI1640 (Invitrogen,
Gaithersburg, MD, USA) supplemented with 5% heat-
inactivated FBS (Invitrogen), 10 μg/ml bovine insulin
(Sigma, St. Louis, MO, USA), and 100 units/ml penicil-
lin-streptomycin (Invitrogen). All cells were maintained
at 37°C in a humidified atmosphere with 5% CO2. Cells
were passaged using trypsinization (0.05% trypsin- ethy-
lenediaminetetraacetic acid (EDTA), Invitrogen) and
counted on a hemocytometer using trypan blue
exclusion.
Humanization models
Animal experiments were conducted in accord with
accepted standards of humane animal care and approved
by the Animal Care and Use Committee at the National
Institutes of Health, USA. Female, 3-week-old NOD/
SCID mice were randomized into groups with a mini-
mum of five mice per group (APA, Frederick, MD,
USA). Mice were anesthetized using inhaled isoflurane
(1.0 to 2.5%) vaporized in oxygen, with an intraperito-
neal injection of analgesic (Sensorcaine) prior to surgi-
cally exposing the abdominal mammary fat pad for
injection. Both abdominal mammary glands were huma-
nized as previously described [19] with the following
additional steps performed where indicated: mice were
supplemented with estrogen via a subcutaneous pellet
(0.72 mg b-estradiol, 90-day release; Innovative Research
of America, Sarasota, FL, USA) at the time of initial
fibroblast injection. Primary human macrophages (7.5 ×
105) were injected during both the initial fibroblast
injection and second injection of fibroblasts along with
primary breast epithelial cells/organoids. Mice were
euthanized two months after final injection; glands were
removed and immediately imaged and/or fixed in 10%
neutral buffered formalin, paraffin-embedded and sec-
tioned. For experiments evaluating fibroblast outgrowths
in the presence or absence of macrophages, the same
steps were performed as described above without the
addition of primary breast epithelial cells/organoids;
glands were harvested 10 days after final injection and
tissues were processed as described.
Tumor formation assays
The right abdominal mammary glands were humanized
+/- macrophages and the mice were supplemented with
estrogen via a subcutaneous pellet, as described above
(five mice were injected for each treatment group). Pri-
mary human macrophages (7.5 × 105) were injected dur-
ing both the initial fibroblast injection and second
injection of fibroblasts along with 1 × 106 T47D breast
cancer cells. Tumor growth was measured using calipers
on a weekly basis. Final tumor volume was calculated
((0.5 × L) × (0.5 × W) × (0.5 × H) × (4/3) × (Π)).
Comparative PCR expression analysis of differentiated
macrophages by colony stimulating factor-1 (CSF-1) or
LPS and INFg
Peripheral blood monocytes were collected from preme-
nopausal women undergoing apheresis and isolated as
described above. Differentiation was performed via treat-
ment with 20 ng/ml of IFNg and LPS or 50 ng/ml of
CSF-1 (Peprotech, Rocky Hill, NJ, USA) in 2% charcoal-
stripped serum for 5 days. RNA was isolated using the
RNeasy kit (Qiagen, Valencia, CA, USA). RNA purity
and integrity were confirmed by Agilent 2100 Bioanaly-
zer. RNA samples (100 ng/sample) were converted into
cDNA (Qiagen) and plated on custom-designed PCR
arrays (SA Biosciences) containing 43 macrophage dif-
ferentiation and polarization genes [20] to determine the
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concordance of macrophage differentiation between the
two treatment protocols. Real-time quantitative PCR
analysis was performed according to the manufacturer’s
protocol using an Applied Biosystems 7900HT Fast PCR
machine. PCR thresholds were identically adjusted then
raw cycle threshold (CT) values were uploaded into the
SA Biosciences webpage for comparative analysis, where
the CSF-1-treated cells were designated as the reference
control. The P-values for the averaged relative gene
expression between the glyceraldehyde 3-phosphate
dehydrogenase (GAPDH)-normalized CSF-1 versus LPS
and INFg treated cells were retrieved and can been seen
in Additional File 1, Table S1 with the average change
in cycle threshold (ΔCT) values. A two-tailed t-test con-
firmed no significantly differential expression between
the two treatment groups across all genes (P = 0.7275).
Only four genes were significantly differentially
expressed, based on P-values (BIRC3, CCR7, CD163,
and PTX3).
Fluorescence in situ hybridization analysis (FISH)
Antigen retrieval
Slides were de-paraffinized by three treatments in xylene
and then dehydrated in 100% ethanol (Sigma). Antigen
retrieval (pepsin) was performed using the Histology Kit
(Dako, K5599; Carpinteria, CA, USA) according to the
manufacturer’s instructions, followed by two washes
with 2× SSC (saline-sodium citrate buffer; 0.3 M NaCl,
30 mM trisodium citrate, pH 7.0)). Specimens were then
dehydrated in an ethanol series and allowed to dry.
Preparation of chromosome paint
The chromosome paint was obtained as previously
described by chromosome flow sorting [21], followed by
degenerate oligonucleotide-primed PCR amplification
[22]. The flow-sorted probe was labeled with biotin-16-
dUTP, and in situ hybridization of the probe was per-
formed in a 5 μl volume. The mixture was precipitated
and dissolved in 14 μl of hybridization buffer (forma-
mide 50%, dextran sulfate 10%, 2 × SSC). The probe
was denatured at 80°C for 10 minutes and re-annealed
at 37°C for 90 minutes before hybridization.
In situ hybridization
The previously prepared slide was denatured in 70% for-
mamide/2 × SSC, at 65°C for 80 sec, and quenched in an
ice-cold 70% ethanol followed by dehydration in 70%,
90%, and 100% ethanol series at room temperature.
Hybridization was carried out in a humidified chamber at
37°C overnight. Slides were washed and counterstained
with diamidino-2-phenylindole (DAPI, 0.8 ng/μl) for 10
minutes and the slides were mounted with antifade.
Microscopy
Analyses were performed under an Axioplan 2 (Zeiss)
fluorescence microscope coupled with a CCD camera
(Photometrics), and images were captured with
FISHview 4.5 software (Applied Spectral Imaging Inc.,
Vista, CA, USA).
Quantitative real-time PCR (RT-PCR)
Total RNA was isolated from primary human mono-
cytes/macrophages or humanized glands using the
RNeasy kit (Qiagen) according to the manufacturer’s
instructions. RNA was reverse transcribed using MMLV
reverse transcriptase (Invitrogen) and primed with oligo-
dT and random hexamers (Invitrogen). The cDNA was
amplified using gene-specific primers for CD14, CD68,
acyl-malonyl condensing enzyme 1 (AMAC1)-1, IL-10,
transforming growth factor (TGF)-b, IL-1b, TNFa, beta-
2 microglobulin (b2M), and GAPDH (Additional File 2,
Table S2) and 2 × Brilliant II Sybr Green QPCR Master-
mix (Stratagene, La Jolla, CA, USA). RT-PCR data were
analyzed via the comparative CT (ΔΔCT) method [23].
Four independent cell isolations from different patient
samples were used for each experiment.
Generation of lentiviral particles and transduction of
macrophages
GFP-expression lentiviral particles were generated using
the PACKH1 kit and 293TN cells (both SBI System
Biosciences, Mountain View, CA, USA). Briefly, 293TN
cells were plated in a 100 mm tissue culture dish (BD
Falcon, Franklin Lakes, NJ, USA) in DMEM (high glu-
cose, Invitrogen) supplemented with 10% FBS such that
the cells grew to 70% confluence overnight. The med-
ium was then replaced with DMEM (high glucose) sup-
plemented with 1% FCS; the plasmid mix composed to
the manufacturer’s instructions was added, and the cells
were incubated at 37°C, 5% CO2 in a humidified atmo-
sphere overnight. The following day, the cell culture
medium containing plasmid was removed; cells were
suspended in RPMI supplemented with 10% FCS, and
passaged into a 150 mm tissue culture dish (BD Falcon).
The virus-containing tissue culture supernatant was col-
lected three days later, filtered (0.45 μm, polyvinylidene
fluoride (PVDF); Millipore, Billerica, MA, USA) to
remove 293TN cells and was used immediately or stored
at -70°C until use. Freshly isolated macrophages were
treated with 8 μg/ml polybrene for 10 minutes prior to
the addition of virus-containing tissue culture superna-
tant (1.0 ml supernatant per 3 mls growth medium).
Cells were incubated with the supernatant for 36 hr,
and then media were replaced with growth medium.
Three days post-transduction, green fluorescent protein
(GFP) expression was visually confirmed using a fluores-
cence microscope.
Proliferation and invasion assays
For all three assays, 24-hr macrophage-conditioned
media were collected from macrophages cultured in
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RPMI containing 2% charcoal-stripped serum +/- estro-
gen (10-10 M) and used for fibroblast treatment.
Proliferation assays: primary human breast fibroblasts
or immortalized human breast fibroblasts proliferating
in log phase were placed in RPMI containing 2% char-
coal-stripped serum (control media) for 24 hr followed
by treatment with either control media +/- estrogen (10-
10 M) or macrophage-conditioned media treated +/-
estrogen, 10 ng/ml TNFa (Peprotech, Rocky Hill, NJ,
USA), 1 or 10 μg/ml Etanercept (Immunex Corporation,
Thousand Oaks, CA, USA) alone or in combination
with macrophage-conditioned media treated +/- estro-
gen. Cells were treated for three days, then trypsinized
and counted. Data represent four independent experi-
ments with different fibroblasts and macrophage isola-
tions used for each assay.
Invasion assays: BD Biocoat Matrigel invasion cham-
bers (8 μm pores) were used according to the manufac-
turer’s protocol (BD Biosciences, Bedford, MA, USA).
Briefly, 125,000 fibroblasts were plated in serum-free
media in the top chamber of transwell inserts and were
allowed to invade through the membrane for up to 16
hr towards either control media +/- estrogen (10-10 M),
or macrophage-conditioned media, or conditioned
media from macrophages treated with estrogen in the
bottom chamber. Following invasion, the cells were
wiped from the top surface of the membrane; the
remaining cells were fixed in methanol and stained with
a 1% toluidine blue solution. Five independent experi-
ments, each with different patient samples (fibroblasts
and macrophage conditioned media) were performed
with each individual experiment plated in triplicate to
ensure repeatability. Cells were imaged and quantified
using NIH Image J 64 software.
For MMP inhibitor invasion studies, 20 or 100 nM
MMP9 inhibitor (Calbiochem, Gibbstown, NJ, USA)
were added to the top chamber of transwell inserts at
the time of plating.
Quantitative multiplex cytokine and chemokine ELISA
assays
A multiplex ELISA kit (Quansys Biosciences, Logan, UT,
USA) was used to quantify a panel of 16 cytokines (IL-
1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13,
IL-15, IL-17, IL-23, IFN-g, TNF a and TNF b) and 16
chemokines (Eotaxin, GROa, I-309, IL-8, IP-10, mono-
cyte chemoattractant protein (MCP)-1 and -2, regulated
on-activation normal T cells expressed and excreted
(RANTES), thymus and activation-regulated chemokine
(TARC), angiopoietin (ANG)-2, basic fibroblasts growth
factors (bFGF), hepatocyte growth factor (HGF), platelet
derived growth factor (PDGF)-BB, tissue inhibitor of
metalloproteinase (TIMP)-1 and -2, and vascular
endothelial growth factor (VEGF) from conditioned
media according to the manufacturer’s protocol.
Zymography and western analysis
Conditioned media were collected, concentrated using
Amicon Ultra centrifugation filter (MWCO 10K, Milli-
pore), and protein concentrations was determined by
Bradford assay (Thermo Scientific; Rockford, IL) accord-
ing to the manufacturer’s instructions.
Zymography: Gelatin zymography was performed
using pre-cast 10% Zymogen 0.1% gelatin gels (Invitro-
gen) according to the manufacturer’s instructions. MMP
activity was visualized as clear bands against a dark blue
background using SimplyBlue SafeStain (Invitrogen)
where the protease has digested the substrate. Identifica-
tion of MMPs was based on the migration pattern of
pro- and activated MMP proteins similarly separated, as
well as by their published molecular weights.
Western blotting: equal concentrations of conditioned
media, as determined by the Bradford assay, were sepa-
rated by SDS-PAGE under reducing conditions. Mem-
branes were blocked in 5% non-fat milk for 1 hr at
room temperature, incubated with primary antibody
(MMP9, MMP2; Abcam) overnight at 4°C, washed, and
incubated with the appropriate secondary antibody con-
jugated to horseradish peroxidase (GE Healthcare, Pis-
cataway, NJ, USA). Peroxidase activity was detected
using the enhanced chemiluminescence detection system
(ECL Plus, GE Healthcare) according to the manufac-
turer’s recommendations. Four independent experi-
ments, each with different patient samples for each cell
type with each individual experiment repeated in dupli-
cate, were performed to ensure repeatability for each
assay.
Immunohistochemistry
Immunohistochemistry was performed with appropriate
controls as described previously [24]. Briefly, 5 μm thick
sections of formalin fixed, paraffin embedded tissue
were prepared from humanized glands. The human spe-
cific CD14 antibody (1:200, Sigma) was used to detect
human monocytes/macrophages in humanized glands,
the human-specific proliferating cell nuclear antigen
(PCNA) antibody (AbCam ab53048) was used to detect
proliferating human fibroblast in the mammary gland,
and the human-specific MMP antibody (1:200 Abcam
AB76003) was used to detect human cell-derived
MMP9. Histosections were pretreated with Dako Target
Retrieval solution and stained using Vectastain ABC kit
(Vector Laboratories; Burlingame, CA, USA) according
to the manufacturer’s instructions. Color was developed
with diaminobenzidine peroxidase substrate kit (Vector
Laboratories) and sections were counterstained with
Fleming et al. Breast Cancer Research 2012, 14:R97
http://breast-cancer-research.com/content/14/3/R97
Page 5 of 18
hematoxylin. A minimum of five glands per treatment
group was analyzed for each assay.
Image quantitation
For determination of the percent of gland humanized,
H&E-stained sections of each gland were imaged with
the Zeiss SteREO Discovery V12 microscope. Total and
humanized areas were determined by histological exami-
nation, measured using the freehand outline tool, and
calculated using Axiovision V4.8 software. Cell invasion
was imaged using an Olympus IX51 microscope at 20×
magnification and quantified using NIH Image J soft-
ware (threshold-standardized; measurement determined
as percent area: red).
Statistical analysis
Data were evaluated for significance using t-tests or
one-way analysis of variance (ANOVA) with the appro-
priate post hoc analysis (Tukey, Bonferroni) using
GraphPad InStat Software version 3.0b (San Diego, CA,
USA). Data were considered significant at P < 0.05.
Results
Murine mammary gland humanization is significantly
enhanced with macrophages and ectopic estrogen
stimulation
Macrophages perform a vital role in mammary develop-
ment and function [7]; therefore, we hypothesized that
the introduction of human macrophages would enhance
humanization of the murine mammary gland. Moreover,
the addition of macrophages would permit an intimate
look at human immune and stromal-derived paracrine
cell interactions in a dynamic in vivo model.
The standard humanization procedure does not
require ectopic estrogen hormonal stimulation for ductal
development of the human epithelial cells as long as the
procedure is performed prior to the end of puberty [6].
However, circulating estrogen levels in the mouse are
lower compared to circulating levels in premenopausal
women, and are essentially comparable to levels found
in postmenopausal women [25]. Additionally, macro-
phages have estrogen receptors [26,27], and estrogens
are known to influence the maturation and function of
macrophages, as well as to have suppressive effects on
the expression of cytokines and other inflammatory
modulators [27]. Thus, as the fibroblasts and macro-
phages used in this study were obtained from premeno-
pausal women, and it is unknown what contributing
factor estrogens have on mammary macrophage func-
tion in this assay, the effects of ectopic estrogen stimula-
tion in the humanization procedure were also
investigated.
Both primary breast fibroblasts and peripheral blood
monocytes/macrophages were isolated from
premenopausal women. It was taken care that addi-
tional, contaminating immune cells were removed via
cell culture selection through monocyte and macro-
phage adherence to plastic. To ensure purity and to
obtain a more homogeneous cell population, cells were
further differentiated into macrophages by IFNg and
LPS treatment. Additional File 3, Figure S1A shows cells
immediately post-isolation and three days post differen-
tiation treatment. Treatment induced a predominately
classic activation of macrophage differentiation, as deter-
mined by quantitative RT-PCR of genes associated with
the classical and alternative activation status of macro-
phages (Additional File 3, Figure S1B). A comparison of
treatment with CSF-1 (100 ng/ml) and IFNg/LPS was
performed as reports suggest that differentiation with
CSF-1 in mammary tissue may differentially influence
macrophage phenotype. Of the 43 macrophage differen-
tiation and polarization genes analyzed, only four genes
were significantly differentially expressed (Additional
File 1, Table S1, P < 0.05; BIRC3, CCR7, CD163, and
PTX3), suggesting no substantial difference between dif-
ferentiation protocols.
In order to study the effect of macrophages and estro-
gen on mammary gland engraftment and outgrowth in a
humanized mouse model of the mammary gland, we
cleared the mammary fat pad, injected fibroblasts and
macrophages in the presence or absence of ectopic
estrogen, and allowed engraftment of the fat pad with
these human stromal cells. Two weeks post-humaniza-
tion, primary breast epithelial cells/organoids and addi-
tional fibroblasts were injected into the glands [6] with
or without the addition of macrophages corresponding
to the initial injections (Figure 1A).
The percent of gland humanized was calculated by
histological examination of the identified humanized
regions followed by measurement of the total and
humanized areas using Axiovision V4.8 software (Figure
1B). In agreement with the standard protocol, the fibro-
blasts outgrowths and epithelial acini-like structures
within the fibroblasts were readily detected in the mur-
ine mammary tissue for all treatments tested (Figure
1C). FISH analysis determined that the cellular out-
growths measured/observed were of human origin (Fig-
ure 1D). The combined treatment of macrophages and
ectopic estrogen stimulation significantly enhanced the
percentage of the total gland humanized (Figure 1E, P <
0.05) as well as enhanced the success rate of engraft-
ment and outgrowth (45% vs. 70% glands displaying out-
growths, data not shown). The glands humanized with
either macrophages or ectopic estrogen treatment alone
exhibited a trend to larger humanized outgrowths com-
pared to the standard humanization protocol. Overall
these data suggest that both the percent of the gland
humanized as well as the engraftment rate was
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significantly enhanced by the combined addition of
macrophages and ectopic estrogen supplementation.
Transitory macrophages enhance fibroblast outgrowth
during early stages of humanization
Having demonstrated enhanced engraftment and huma-
nization of the mouse mammary fat pad by exposure to
estrogen and human macrophage injection, without
observing an altered histology of the humanized areas
between different treatment groups, we next asked if a
combined macrophage/estrogen treatment might influ-
ence overall cellular growth or enhance the invasiveness
of human fibroblasts.
Immunohistochemistry using a human-specific CD14
antibody revealed that no human macrophages were
present at the time of gland collection (two months
post-final injection of cells, data not shown). Therefore,
we examined the timing of the disappearance of the
human macrophages from the gland using freshly iso-
lated macrophages transduced with lentiviral particles to
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Figure 1 Human macrophages enhance humanization of the murine mammary gland. Murine mammary glands were humanized +/- the
addition of primary human macrophages and exogenous estrogen supplementation. Humanization was repeated in two independent
experiments using different patient/donor-derived normal breast fibroblasts and macrophages between experiments. The primary breast
epithelial cells and organoids used for all experiments originated from the same patient. A minimum of ten glands from each treatment group
was used for analyses. (A) Schema representing steps of procedure. (B) Total and humanized areas were determined after two months of
growth by histological examination of H&E-stained tissue, imaged with the Zeiss SteREO Discovery V12 and calculated using Axiovision V4.8
software. (C) H&E-stained humanized histosections. Images were captured at 40× (left) and 20× (right) magnification. (D) Fluorescence in situ
hybridization (FISH) analysis of humanized mammary glands. Paraffin-embedded histosections of humanized mammary glands were subjected to
FISH analysis to confirm the species of origin for the identified regions of humanization. Human X chromosome probe was labeled with biotin-
16-dUTP (green). Slides were counterstained with diamidino-2-phenylindole (DAPI, blue) and mounted with antifade. Analysis was performed
using the Zeiss Axioplan 2 fluorescence microscope coupled with a CCD camera and images were captured with FISHview 4.5 software at 100×
magnification. (E) Data represent percent humanization ± standard error (SE) of two independent experiments. A minimum of ten glands per
treatment group were measured. *P < 0.05. FB, fibroblast conditioned media; j, macrophage conditioned media; E2, estrogen treatment.
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induce expression of GFP (Figure 2A). Glands were
humanized and collected 2, 6, 10 and 40 days post-injec-
tion. Presence of macrophages was measured by three
methods: immunofluorescent detection of GFP immedi-
ately following excision of the glands, immunohisto-
chemical detection using a human-specific CD14
antibody on paraffin-embedded histosections, and RT-
PCR of RNA isolated from the glands using human spe-
cific primers to CD14 and CD68.
Macrophages were readily detected two days post-
injection by all three methods. RT-PCR analysis showed
a decrease of human CD14- and CD68-mRNA between
day 2 and day 6 after injection of human macrophages
into the mammary fat pad (Table 1). Human CD14 and
human CD68 were no longer detectable 10 days after
injection of macrophages; GFP-labeled human macro-
phages were also readily detected in the mammary fat
pad 2 days and 6 days after inoculation with GFP-
labeled macrophages (Figure 2A, B). Likewise, we
demonstrated the presence of human macrophages in
the mammary fat pad 6 days after inoculation by immu-
nohistochemistry for human CD14 (Figure 2B). At days
24 and 40, all methods confirmed the lack of human
macrophages within the humanized gland (data not
shown). Taken together, these data demonstrate that
human macrophages are only temporarily present in the
inoculated mammary fat pad. This indicates a transient
interaction of macrophages, fibroblasts, and the stroma
of the mammary fat pad during the first stage of mam-
mary fat pad humanization, which subsequently
enhances future engraftment with human breast epithe-
lial cells.
To test this hypothesis, glands were humanized with
fibroblasts and ectopic estrogen, with fibroblasts and
macrophages, or with a combination of all three to eval-
uate the initial step of humanization, the outgrowth of
fibroblasts into the murine mammary fat pad. After ten
days of growth, the glands were harvested as in the
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Figure 2 Transitory macrophages enhance early states of fibroblast outgrowth during humanization. (A) Primary human monocytes/
macrophages were isolated via Ficoll separation from apheresis product, differentiated, and then transduced with green fluorescent protein
(GFP). Images show cells 48 hr post-transduction with GFP or negative controls. Cell nuclei were stained with diamidino-2-phenylindole (DAPI)
for visualization (blue, bottom panels). (B) Primary breast fibroblasts were injected with or without the GFP-expressing macrophages in the
presence or absence of ectopic estrogen. Six days post-injection freshly excised glands were imaged using a GFP filter. Immunohistochemical
detection of human macrophages (day six) humanized glands using a human-specific CD14 antibody (top panels) or corresponding negative
controls (bottom panels; scale bar = 200 μm). (C) Percent gland humanized after ten days of fibroblast growth +/- estrogen +/- macrophages.
Total and humanized areas were determined by histological examination, imaged with the Zeiss SteREO Discovery V12 and calculated using
Axiovision V4.8 software. Data represent percent humanization ± SD. Four glands per treatment group were measured. *P < 0.01. (D) Tissues
were subjected to immunohistochemical analysis with a proliferating cell nuclear antigen (PCNA) antibody to identify proliferative cells. Stained
histosections were imaged and quantified using NIH Image J software. Data represent average of four counts per gland ± SD. Three glands per
treatment group were measured. *P < 0.02.
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standard protocol for the initial humanization step. As
shown in Figure 2C, the combination of treatments sig-
nificantly enhanced fibroblast growth throughout the
gland compared to the addition of macrophages or ecto-
pic estrogen alone (P < 0.01). These data suggest that
the enhanced humanization is due to an increase in the
overall area of human stromal outgrowth, thereby pro-
viding a larger humanized area for acini proliferation
and outgrowth. Indeed, immunohistochemistry revealed
significant increase of PCNA-positive, proliferating
fibroblasts in glands humanized with macrophages com-
pared to fibroblasts alone (Figure 2D, P < 0.02).
Collectively, these data indicate that the stimulatory
mechanisms of the macrophages on humanization are
transitory, as the macrophages disappear from the mur-
ine gland within 10 days post-injection. However, our
data indicate that their presence at the time of injection,
and within a week thereafter, has a significant and long
lasting effect on mouse mammary gland humanization
with human fibroblasts and consecutive engraftment
with human mammary epithelial cells. The increased
proliferation of human fibroblasts might be a relevant
mechanism for the observed increased humanization of
the mouse mammary fat pad.
Macrophages enhance fibroblast proliferation, in part,
through a TNFa dependent mechanism
We determined that paracrine interactions between pri-
mary macrophages and fibroblasts enhance humaniza-
tion of the gland. To identify potential mechanisms by
which the macrophages enhanced humanization, four
different in vitro cell proliferation assays were used to
determine if (1) direct cell-to-cell contact was necessary
between the fibroblasts and macrophages, or (2) if
secreted factors from the macrophages were sufficient to
induce fibroblasts proliferation, and (3) whether estro-
gen enhanced these effects. Fibroblasts were either co-
cultured directly with macrophages in the presence or
absence of estrogen treatment, cultured in the presence
of the macrophages but separated from physical contact
with a transwell insert, treated with macrophage-condi-
tioned media, or treated with co-conditioned media
from fibroblast and macrophage direct co-cultures
(Additional File 4, Figure S2). Overall, when fibroblasts
were cultured in the presence of the estrogen-treated
macrophage-conditioned media, cell proliferation was
equivalent or greater than any other treatment condi-
tion. Based on these initial results, we more rigorously
examined the effects of macrophage-conditioned media
in the presence or absence of estrogen treatment using
seven freshly isolated individual fibroblasts patient sam-
ples each treated with the conditioned media from three
different macrophage patient samples (Figure 3). These
data confirm the original observation that fibroblasts
cultured in the presence of the estrogen-treated macro-
phage-conditioned media exhibit significantly enhanced
cell proliferation compared to control or estrogen treat-
ment (P < 0.01).
To identify macrophage-specific secreted factors respon-
sible for the increase in fibroblast proliferation,
Table 1 Time course of real time-PCR detection of human
macrophages in humanized glands
CD14 SD CD68 SD GAPDH SD
Day 2
+ E2 No CT No CT 22.28 0.26
+ Macrophages 23.88 0.10 28.18 0.24 21.59 0.24
+ E2 and Macrophages 26.36 0.16 28.52 1.50 22.69 0.23
Day 6
+ E2 No CT No CT 22.48 0.31
+ Macrophages 28.37 3.40 30.02 a 1.39 20.88 0.70
+ E2 and Macrophages 27.65 4.92 30.01
a 3.57 19.69 0.91
Day 10
+ E2 No CT No CT 19.16 0.33
+ Macrophages 31.05a 0.81 30.81a 1.55 18.51 0.15
+ E2 and Macrophages 29.43 1.51 31.28
a 1.12 18.65 1.13
Controls
Human monocytes 14.4 0.14 16.3 0.16 20.59 0.07
Human macrophages 16.5 0.16 20.2 0.09 21.00 0.20
Murine mammary gland No CT No CT 21.45 0.14
aCycle Threshold (CT) values over 30 were not considered positive for a
detectable signal. Analysis was terminated at 32 cycles. E2, ectopic estradiol
treatment; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Figure 3 Macrophages stimulate primary breast fibroblast
proliferation. Primary human monocytes/macrophages were
isolated, differentiated, treated +/- estrogen (10-10 M) for 24 hr and
conditioned media were collected. Primary human breast fibroblasts
were placed in 2% charcoal-stripped serum-containing media 24 hr
prior to treatment +/- estrogen or with macrophage-conditioned
media +/- estrogen for three days, then trypsinized and counted.
Data represent four independent experiments with different
fibroblasts and macrophage isolations used for each assay. *P <
0.01. j, macrophage conditioned media; E2, estrogen treatment.
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quantitative multiplex cytokine and chemokine ELISA-
based assays were performed. Three independent mono-
cyte/macrophage isolations were prepared, followed by
differentiation and treatment for 24 hr in the presence
or absence of estrogen. Half of the macrophage-condi-
tioned media were immediately frozen and stored for
analysis, and half were placed on fibroblast cultures for
24 hr to obtain co-conditioned media. Each of the three
macrophage conditioned media samples were used to
treat a minimum of two independent breast fibroblast
isolations and the co-conditioned media were collected
from each individual fibroblast sample. One striking
observation was a significant decrease in TNFa after
macrophage-conditioned media was used to treat the
fibroblasts (mean ± SD, 60.9 ± 1.1 pg/ml vs. 17.6 ± 2.8
pg/ml, respectively; P < 0.001), potentially suggesting
cellular uptake. TNFa has been reported to stimulate
dermal and foreskin fibroblast chemotaxis and prolifera-
tion in vitro and in vivo [28-30]; therefore, we tested the
ability of the macrophage-derived TNFa to stimulate
breast fibroblast proliferation. Initial studies were per-
formed using hTERT immortalized breast fibroblasts [6]
to determine whether breast fibroblasts proliferate in
response to TNFa stimulation, and to optimize the con-
centration of TNFa inhibitor (Etanercept) (data not
shown). Immortalized and primary breast fibroblasts
were then treated with estrogen-stimulated macrophage-
conditioned media or TNFa (10 ng/ml) in the presence
or absence of the TNFa inhibitor (10 μg/ml). As shown
in Figure 4A and 4B, the proliferation of breast fibro-
blasts treated with estrogen-stimulated macrophage-con-
ditioned media was significantly inhibited in the
presence of the TNFa inhibitor (P < 0.05). Macrophage-
conditioned media enhanced fibroblast proliferation
more than TNFa alone (Figure 4B), suggesting that
other factors also contributed to cell proliferation; how-
ever, our data demonstrate that enhanced proliferation
occurs, in part, through a TNFa dependent mechanism.
Macrophages stimulate enhanced fibroblast invasion
through upregulation of MMP-9 activity
During humanization, the fibroblasts injected into the
gland must proliferate as well as migrate throughout the
gland, which requires the active degradation of the base-
ment membrane and extracellular matrix of the murine
gland. Having already determined that macrophages
enhanced fibroblast proliferation, we next investigated
whether stimulation by macrophages, estrogen, or the
combination, enhanced fibroblast invasion as well. Pri-
mary human breast fibroblasts were subjected to trans-
well Matrigel invasion assays using either control or
macrophage-conditioned media containing 2% charcoal-
stripped serum +/- estrogen (10-10 M) as chemoattrac-
tants. Twenty-four hours post-seeding, invaded cells
were stained with toluidine blue, imaged, and quantified
(Figure 5A). Results from five independent experiments
using different fibroblast and macrophage isolations for
each assay demonstrated that both macrophage-condi-
tioned media and estrogen-stimulated macrophage-con-
ditioned media significantly increase fibroblast invasion
above controls (Figure 5B, P < 0.01). Estrogen alone
enhanced fibroblast invasion, but the increase was not
significant. These data demonstrate that chemokines
and additional molecules secreted from the macrophages
enhance extracellular matrix degradation and fibroblasts
invasion, potentially replicating another mechanism by
which macrophages enhance humanization in vivo.
These results were similar to those obtained in the in
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Figure 4 Macrophage-secreted TNFa enhances breast fibroblast proliferation. Primary human monocytes/macrophages were isolated,
differentiated, treated with estrogen (10-10 M) for 24 hr and conditioned media (CM) were collected. Primary human breast fibroblasts were
placed in 2% charcoal-stripped serum-containing media 24 hr prior to treatment with 2% charcoal-stripped serum-containing media + estrogen
(10-10 M), media + 10 ng/ml TNFa (T), + TNFa inhibitor (I), the combination TNFa + inhibitor (T+I), macrophage-conditioned media (CM) or CM
+ TNFa inhibitor (CM+I). For each assay, cells were treated for three days then trypsinized and counted. Data shown are from one representative
experiment of two independent experiments. *P < 0.05 from CM.
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vitro proliferation assays; either macrophages alone or
estrogen-stimulated macrophages were able to signifi-
cantly enhance fibroblast behavior. In contrast to these
in vitro measurements of cell behavior, ectopic estrogen
stimulation is required to obtain the most significant
amount of humanization in vivo.
Given the known role of matrix metalloproteinases
(MMPs) in cell invasion and mammary development
[31,32], we hypothesized that upregulation of MMPs
was one mechanism by which macrophages enhanced
fibroblasts invasion and thus overall humanization.
Gelatin zymography and western blot analyses were
used to evaluate the levels and activity of MMPs from
the conditioned media of either fibroblasts alone or sti-
mulated with macrophage-conditioned media. Mem-
branes were stained with Ponceau S to ensure equal
loading of protein (Additional File 5, Figure S3). Four
independent experiments, each with different patient
samples for each cell type with each individual
experiment repeated in duplicate, were performed to
ensure reproducibility for each assay. Results demon-
strate that fibroblasts treated with macrophage-condi-
tioned media had significantly increased MMP9 activity
and expression (Figure 6A, B) while MMP2 levels
remained relatively unchanged regardless of treatment.
An additional increase in MMP9 activity and levels in
the conditioned media of fibroblasts treated with the
estrogen stimulated macrophage-conditioned media was
also observed (Figure 6A, B; quantification in Additional
File 5, Figure S3).
To confirm our in vitro findings, the levels of MMP9
during early stages of humanization were examined. Par-
affin-embedded sections of glands humanized with
fibroblasts and ectopic estrogen or fibroblasts with pri-
mary human macrophages and ectopic estrogen were
collected 2, 6 (Figure 6C), and 10 days post-injection
and analyzed immunohistochemically using a human-
specific MMP9 antibody. Analysis at each time point
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Figure 5 Enhanced primary breast fibroblast invasion in the presence of human macrophages conditioned media. Primary human
macrophages were treated +/- estrogen (10-10 M) in 2% charcoal-stripped serum-containing media and 24 hr-conditioned media were collected.
Primary human breast fibroblasts were seeded in serum-free media into Matrigel invasions chambers in triplicate. Chemoattractants were 2%
charcoal-stripped serum (control), control media + estrogen (10-10 M), macrophage-conditioned media, or conditioned media from macrophages
treated with estrogen. (A) 24 hr post-seeding, invaded cells were stained with toluidine blue (top panels), imaged and quantified using NIH
Image J software (measurement highlighted in red, bottom panels). (B) Data represent average area measurement of invaded cells +/- standard
error (SE) of five independent experiments. *P < 0.01 above control or E2 treatment. j, macrophage conditioned media; E2, estrogen treatment.
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expressed significantly higher levels of MMP9 in the
humanized regions of the gland, similar to results from
zymography and western analyses, demonstrating an
increase in MMP9 when macrophages are present.
To further support our hypothesis that increased
activity of MMPs enhances humanization, we performed
additional assays investigating the ability of macrophage-
stimulated MMP9 activity to increase fibroblast invasion.
Primary and immortalized human breast fibroblasts
were again subjected to transwell Matrigel invasion
assays using estrogen-stimulated macrophage-condi-
tioned media as the chemoattractant; however, a specific
MMP9 inhibitor was added to the fibroblasts when pla-
ted in the transwell chamber. Invaded cells were stained
with toluidine blue 24 hr post-seeding, imaged, and
quantified (Figure 7A). Results from two independent
experiments using different fibroblasts and macrophage
isolations for each assay demonstrated that inhibition of
MMP9 activity decreased fibroblast invasion in a dose-
dependent manner (Figure 7B, P < 0.01). However, it is
noted that in these in vitro studies it is not possible to
distinguish chemotaxis from chemokinesis. Collectively,
our results demonstrate that macrophage-stimulated
enhanced humanization is due in part, to increased
MMP9 degradation of extracellular matrix, thereby facil-
itating fibroblast invasion throughout the gland.
Macrophages stimulate enhanced tumor formation in
humanized glands
Previous studies show that the source of stromal fibro-
blast can significantly affect epithelial cell morphology
and proliferation, as well as tumor engraftment and
aspects of behavior [6,33-39]. Therefore, an initial study
was performed to observe the effect of macrophages on
breast cancer cell engraftment of humanized glands.
This experiment is one initial experiment, used only to
support the need for future tumorigenesis studies using
this model. The right abdominal gland was humanized
in the presence or absence of estrogen-stimulated
macrophages, and mice were supplemented with subcu-
taneous estrogen pellets (five mice were injected in the
control group and five mice in the treatment group).
Two weeks post-humanization, 1 × 106 T47D breast
cancer cells were injected with fibroblasts or fibroblasts
and macrophages into the humanized region. As shown
in Figure 8, the glands humanized with macrophages
had enhanced engraftment rate and tumor growth com-
pared to the glands humanized with fibroblasts alone
B
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Figure 6 Primary macrophage conditioned media stimulates primary breast fibroblast matrix metalloproteinase (MMP)-9 secretion.
Primary human macrophages were treated +/- estrogen (10-10 M) in 2% charcoal-stripped serum-containing media and 24 hr-conditioned media
were collected. Primary human breast fibroblasts were placed in 2% charcoal-stripped serum-containing media 24 hr prior to treatment with 2%
charcoal-stripped serum, control media + estrogen (10-10 M), macrophage-conditioned media, or conditioned media from macrophages treated
with estrogen. (A) Gelatin zymography. (B) Western blot analysis. Results are representative of a minimum of three independent experiments
with different fibroblasts and macrophage isolations. (C) Murine mammary glands were humanized and +/- the addition of primary human
macrophages and exogenous estrogen supplementation. Immunohistochemical analysis using a human-specific MMP9 antibody of paraffin-
embedded histosections glands six days post-humanization. Scale bar = 200 μM. FB, fibroblast conditioned media; j, macrophage conditioned
media; E2, estrogen treatment.
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(one tumor in the standard humanized glands out of
five injected mice vs. three tumors out of five mice in
the macrophage group). Initial studies show no overt
differences in tumor morphology between treatment
groups and additional studies are under investigation.
Similar to humanized studies, no human macrophages
were detected in the xenograft tumors or surrounding
tissues at the time of collection.
Discussion
This study demonstrates that intricate, temporary,
stroma-derived paracrine cell interactions in a huma-
nized in vivo model system can improve engraftment of
the mammary fat pad. Based on the heterogeneic mouse
model of the human mammary gland developed by
Kuperwasser et al. [6] we expanded upon the model by
incorporating human immune cells, in addition to
human fibroblasts, to investigate multi-cellular primary
human cell interactions in vivo. The addition of
macrophages enhanced humanization of the gland by
augmenting fibroblast proliferation and invasion
throughout the gland, thereby providing a larger stromal
bed for human breast epithelial cell proliferation and
formation of acini and ductal structures. We have iden-
tified two specific paracrine mechanisms involved in
enhancement of humanization: increased fibroblast pro-
liferation stimulated by macrophage-derived TNFa as
well as a macrophage-stimulated increase in MMP9
expression and proteinase activity. Our observed in vivo
results have been confirmed with in vitro studies, again
highlighting the value of this model to interchangeably
support in vitro and in vivo results.
It is of note that no gross morphologic differences
were observed within the epithelial structures of the
macrophage- and estrogen-stimulated humanized out-
growths compared to the standard protocol (Figure 1C).
However, one should note that in the present study we
did not investigate epithelial function or differentiation
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Figure 7 Macrophage-conditioned media-enhanced breast fibroblast invasion requires matrix metalloproteinase (MMP)-9. Primary
human macrophages were treated +/- estrogen (10-10 M) in 2% charcoal-stripped serum-containing media and 24 hr-conditioned media were
collected. Primary human breast fibroblasts were seeded in serum-free media into Matrigel invasion chambers in triplicate. Chemoattractants
were conditioned media (CM) from macrophages treated with estrogen (10-10 M) +/- the indicated amount of MMP9 inhibitor. (A) 24 hr post-
seeding, invaded cells were stained with toluidine blue; scale bar = 500 μm. (B) Data represent average number of invaded cells +/- SD; four
areas were measured per chamber. *P < 0.01.
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during pregnancy and lactation. The critical role macro-
phages play in orchestrating these important develop-
mental stages of the mammary gland is continually
emerging [9,40-42]; future experiments using this in
vivo model to further observe macrophage function dur-
ing pregnancy and lactation will be an interesting ave-
nue to explore. The activation stage of macrophages has
recently been reported to have a unique function during
different stages of mammary gland differentiation [43]
and has been shown to differentially influence breast
cancer cell behavior [44]. This model system enables
novel, in vivo studies investigating the role of human
macrophages in normal breast, as well as in breast can-
cer xenograft studies. However, it should be noted that
the addition of macrophages may not have an effect on
epithelial cell differentiation, as the introduction of M1-
type macrophages may have created more of an initial
wound healing microenvironment, resulting in improved
human fibroblast engraftment during the resolution
phase when human macrophages are no longer present.
In the present study, peripheral blood monocytes iso-
lated from premenopausal women were differentiated
using the classical method of adherence to plastic fol-
lowed by treatment with LPS and IFNg [45,46]. IFNg is
an immunostimulatory cytokine that primes monocytes
for differentiation in response to LPS [47]. This method
was chosen as it produced a more homogeneous popu-
lation of macrophages as compared to other differentia-
tion methods, and the macrophages produced higher
amounts of proinflammatory cytokines compared to
alternatively activated macrophages (Additional File 1,
Figure S1). Although limited data exist on the role of
proinflammatory cytokines in the human breast, IFNg
has been reported to be present in the breast during
development and milk production [48]. In vitro studies
have shown that human mammary epithelial cells con-
tain the IFNg receptor and are sensitive to IFN-g stimu-
lation, resulting in inhibition of proliferation, disruption
of cell polarity and tight junctions; all are critical steps
in milk stasis, involution and tissue remodeling during
outgrowth [49-51]. Therefore, the presence of IFNg dur-
ing stages of breast tissue remodeling suggests the
potential for monocyte/macrophage exposure in breast
tissue, and a role for IFN-g in breast function. However,
many of the studies defining the role of mammary
macrophages have focused on the role of CSF-1, which
regulates macrophage behavior, morphology and moti-
lity and, through a series of eloquent genetic mouse-
model experiments, has been shown to be critical for
mammary gland development and function [52,53].
Gyorki et al. (2009) demonstrated that mammary
macrophages contribute to normal stem/progenitor cell
function in the developing mouse mammary gland,
using both the Csf1op/op mice and the clondronate-con-
taining liposomes ablation method [54]. They suggest
that mammary stem cells require macrophage-derived
factors to be fully functional. Our data show that in
vitro treatment of the cells with either CSF-1 or LPS/
IFNg has no significant effect on 39 of the 43 differen-
tiation and polarization genes analyzed (Additional File
1, Table S1), suggesting no substantial difference
between differentiation protocols. However, the possibi-
lity exists that upon introduction to the mouse mam-
mary fat pad, the local and systemic factors had an
additional influence on the human macrophages pheno-
type. Given the wealth of data on CSF-1 in the
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Figure 8 Macrophages enhanced tumor growth of humanized glands. Murine mammary glands were humanized +/- the addition of
primary human macrophages and exogenous estrogen supplementation (5 mice per treatment group). Two weeks post-humanization, 1 × 106
T47D breast cancer cells were injected with fibroblasts or fibroblasts and macrophages into the humanized region. One tumor out of a total of
five injected mice developed tumors in the standard humanized treatment group, while three tumors out of five injected mice developed
tumors in the glands humanized with macrophages. Data represent mean +/- SD.
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developing gland, it would be of interest to observe the
effect of CSF-1-differentiated human macrophages on
humanization of the mammary fat pad.
In the present study, it is not known whether the
macrophages stimulated a wound-healing response or
other developmental processes to enhance humanization
of the mouse fat pad. The LPS/IFN-g-stimulated macro-
phages exhibited increased proinflammatory cytokines
compared to freshly isolated macrophages. As shown in
an eloquent study by Vaillant et al. [55], an increase in
growth factors and cytokines can bias the numbers of
stem cells present in normal or tumoral tissue, as well
as alter progenitor/stem cell proliferation. Thus, it is
possible that the secretion of proinflammatory cytokines
by the LPS/IFN-g-stimulated macrophages may have
influenced humanization of the glands by stimulating
progenitor cell response. Conversely, the increase in
cytokine production by the macrophages potentially
mimicked a wound response, thereby enhancing the
outgrowth of the fibroblasts into the mammary fat pad
in this model. Acute wounding was shown to increased
tumor growth in a syngeneic mouse breast cancer
model and, moreover, the effect of accelerated tumor
growth due to wounding could be mimicked by acellular
wound fluid [56]. We evaluated whether the effects of
the macrophages on humanization could be stimulated
using acellular-conditioned media (Additional File 6,
Figure S4); however, concentrated macrophage-condi-
tioned media were not capable of enhancing fibroblast
humanization throughout the mammary gland. This
suggests that either the physical presence of the macro-
phage in the mammary gland was necessary for
enhanced humanization, or that human macrophage
interactions with the murine stromal cells were neces-
sary for the enhanced humanization observed.
Macrophage cytokine and chemokine production is
reportedly suppressed by estrogen, often mediated by
transcriptional or nongenomic repression of gene
expression [27]. In the present study, estrogen had no
effect on TNFa secretion (60.9 ± 1.1 vs. 60.1 ± 2.1 pg/
ml); however, estrogen treatment alone or in combina-
tion with macrophage-conditioned media significantly
decreased the concentration of the chemokines IL-8 and
IL-23, as well as the chemokine Eotaxin (Additional File
7, Table S3, *P < 0.05). We hypothesize that the estro-
gen-stimulated additive effects on enhanced fibroblast
humanization of the gland are due to combinatory
effects of estrogen-directed suppression of macrophage-
derived inhibitory cytokines/chemokines, as well as
estrogen-stimulated proliferation in combination with
other growth factors in vivo. The extensive and complex
mechanisms of estrogen signaling are known to have a
multitude of effects on breast cell growth and function
[57-60]. Therefore, it is not surprising that exogenous
estrogen augments the macrophage-stimulated prolifera-
tion of steroid-sensitive breast stromal cells in this in
vivo model.
In this report we primarily investigated normal human
breast cell interactions; however, this model is easily
adaptable for studying primary human immune and
stromal cell interactions in the breast tumor microenvir-
onment. Many of the signaling mechanisms that control
the outgrowth of cells throughout the breast during
pubertal development and the continual repopulation of
cells during steroid-driven cycles of growth are often
exploited by tumor cells to support their parasitic
growth and invasive properties. It is well acknowledged
that immune cells play a significant and complex role in
promoting tumorigenesis and metastasis [17]. Macro-
phages, in particular, have been shown to migrate to
distinct tumor sites and, in response to the varying loca-
lized stimuli, release specific growth factors and mole-
cules to regulate cancer cell proliferation, invasion,
angiogenesis, and metastasis [13]. Our preliminary study
observing the effect of macrophages on tumor formation
demonstrated an increase in tumor cell engraftment and
growth. Previous studies have shown a suppressive effect
of normal fibroblasts on tumor formation [6,33-39],
potentially explaining the low efficiency of tumorigenesis
in the glands humanized with primary breast fibroblasts.
Additionally, as stated above, the high level of cytokine/
chemokine production secretion from the macrophages
potentially stimulated a wound response or augmented
tumor progenitor cell proliferation similar to results
shown in other studies [54-56]. It is well documented
that inflammation and a wound-like signature promotes
breast cancer tumorigenesis and is highly prognostic of
breast cancer survival [61-63]. TNFa is a known media-
tor of the inflammatory response [63], and is a potential
candidate for a mediator of the observed increase in
tumorigenesis. It was recently shown that TNFa secre-
tion from cultured macrophages was significantly
increased after incubation with breast cancer tumor
supernatants, and resulted in enhanced tumor cell inva-
sion and adherence to endothelium [64]. Additionally,
inhibition of TNFa has been shown to decrease breast
cancer cell aggressive behavior, including metastasizing
to bone [65]. Moreover, macrophages have been shown
to play a key role in breast cancer; tumor-associated
macrophages produce factors that promote tumor cell
proliferation, migration, angiogenesis, tissue remodeling,
reduce the local immune response to tumor cells, and
are associated with poor prognosis in breast cancer
patients [17,64,66-68]. While further studies are required
to fully understand the role of macrophages in the
humanized gland, this report presents the prospect of
studying primary human macrophage/tumor interactions
in a dynamic in vivo model; potentially further
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advancing our knowledge of the tumor-derived signals
that promote distinct macrophage behavior.
Conclusions
Our findings demonstrate intricate immune and stromal
cell paracrine interactions in a humanized in vivo model
system. We confirmed our in vivo results with in vitro
analyses, highlighting the value of this model to inter-
changeably substantiate in vitro and in vivo results. It is
critical to understand the signaling networks that drive
paracrine cell interactions to fully understand the basic
mechanisms of breast cell function. Moreover, many of
the signaling mechanisms that control the outgrowth of
cells throughout the breast during pubertal development
and the continual repopulation of cells during steroid-
driven cycles of growth are often exploited by tumor
cells to support their parasitic growth and invasive prop-
erties. This report presents a dynamic in vivo model to
study primary human immune/fibroblast/epithelial inter-
actions. This model can readily be applied to advance
our knowledge of the stromal-derived signals that pro-
mote tumorigenesis.
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